Pfizer shares jump 8% on Medicaid deal with TrumpPfizer shares surged after the US drugmaker agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration...
01 Oct, 2025, 09.42 AM IST
Trump to announce Pfizer price cuts as White House presses drugmakersPfizer will announce plans to cut prices on several medicines in the U.S., alongside a $70 billion investment in research, development and ...
30 Sep, 2025, 10.05 PM IST
Trump pressures 17 pharma CEOs to cut US drug pricesDonald Trump has asked major pharmaceutical companies to lower US drug prices. He wants them to match the prices paid in other countries. T...
01 Aug, 2025, 02.37 PM IST
US reaches deal with Moderna for omicron Covid 19 vaccineThe order of the bivalent shot follows the announcement last month that the federal government had secured 105 million doses of a similar v...
29 Jul, 2022, 06.51 PM IST
US extends expiration dates on J&J COVID vaccine to 6 monthsThe change gives health providers more time to use remaining shots sitting at pharmacies, hospitals and clinics. After plateauing earlier t...
29 Jul, 2021, 09.24 AM IST
Canada to get Pfizer vaccine before the end of this year, says Prime Minister TrudeauTrudeau had come under criticism from opposition parties for saying Canadians won't be among the first to get a vaccine against COVID-19 be...
07 Dec, 2020, 10.37 PM IST
Pfizer’s patent claim for Xeljanz dismissedThe base compound of the drug has been granted patents in India and Pfizer attempted to secure additional patents for the follow-up improve...
07 Sep, 2015, 04.45 PM IST
Pfizer isolated in campaign against Indian patent regime, say Indian pharma allianceThe label is the lowest classification any country can find itself in on a US made rating scale for intellectual property protection.
30 Apr, 2014, 10.44 AM IST
- Ranbaxy gets USFDA nod to sell Lipitor
The approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote
01 Dec, 2011, 09.58 AM IST
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30
Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.
09 Sep, 2011, 05.18 AM IST
- Pfizer, Dr Reddy's settle patent suit over Lipitor
Pfizer's Lipitor is the world's largest-selling drug, which generated about $7 billion in sales last year in the US alone.
01 Sep, 2011, 03.20 AM IST
- Ranbaxy's Lipitor copy fate next week
A US court will decide next week if Ranbaxy can launch its low-priced version of the world's best selling drug Lipitor in the American mark...
30 Apr, 2011, 01.57 AM IST
- Orchid Chemicals settles case with Pfizer Inc; stock down
Hyderabad-based Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost versio...
19 Apr, 2011, 10.03 AM IST
- Orchid Chemicals settles case with Pfizer Inc
Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost version of the America...
19 Apr, 2011, 06.43 AM IST
- Ranbaxy stocks up as USFDA opposes Mylan’s request
Shares of Ranbaxy Laboratories were at Rs 468, up 1.41 per cent on the NSE. It touched a high of Rs 473.70 and low of Rs 466.30 in trade so...
08 Apr, 2011, 12.04 PM IST
- USFDA nod likely for Ranbaxy generic drug
The US drug regulator has opposed American firm Mylan Inc's request to strip Ranbaxy Laboratories of its six-month exclusive rights to sell...
08 Apr, 2011, 01.30 AM IST
- Cipla in talks with global cos for research agreement
Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
02 Dec, 2009, 12.36 AM IST